Collegium Pharmaceutical, Inc. COLL Segment — Segment Reporting, Other Segment Item, Amount
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount?
- Collegium Pharmaceutical, Inc. (COLL) reported segment — segment reporting, other segment item, amount of $6.18M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount changed year-over-year?
- Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount increased by 225.0% year-over-year, from $1.9M to $6.18M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount?
- Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s segment — segment reporting, other segment item, amount has grown at a -48.0% compound annual growth rate (CAGR), from $31.3M to $4.39M.
- What does segment — segment reporting, other segment item, amount mean?
- Captures miscellaneous or non-recurring items specific to the business segment that do not fall into standard operating expense categories. It provides transparency into unique operational events or adjustments affecting segment-level performance.